1-15 of 15
Loretta J. Nastoupil, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Health Equity: Are We Missing the Mark With CAR T-cell Therapy?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2024) 21 (4)
https://doi.org/10.1182/hem.V21.4.2024411
Published: 2024
Articles

Sequencing of Therapy Matters in the Era of Autologous Chimeric Antigen Receptor T-cell Therapy

Free
Karan L. Chohan, MD, Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2024) 21 (3)
https://doi.org/10.1182/hem.V21.3.202438
Published: 2024
Articles

Do Bispecific Antibodies Open the Door to Novel–novel Combinations for Patients With Relapsed/Refractory Large B-cell Lymphoma?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2024) 21 (2)
https://doi.org/10.1182/hem.V21.2.202424
Published: 2024
Articles

Pola-R-CHP: A Dramatic Shift in the Frontline Treatment Paradigm for Diffuse Large B-cell Lymphoma, or a Small Step Forward?

Free
Neha Akkad, MD, Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2024) 21 (1)
https://doi.org/10.1182/hem.V21.1.202418
Published: 2024
Articles

MAHOGANY: Will it Establish Zanbrutinib, a Second-generation Bruton Tyrosine Kinase Inhibitor, as a Preferred Targeted Therapy for Relapsed/Refractory Follicular and Marginal Zone Lymphomas?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.202369
Published: 2023
Articles

Moving On Up: Second-line Axicabtagene Ciloleucel Improves Overall Survival in Patients With LBCL

Free
Dustin B. McCurry, MD, Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (5)
https://doi.org/10.1182/hem.V20.5.2023511
Published: 2023
Articles

Will CAR T-Cell Therapy Be the Preferred Modality in Frontline Treatment of Large B-Cell Lymphoma?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (4)
https://doi.org/10.1182/hem.V20.4.2023414
Published: 2023
Articles

The Yin and Yang of CAR T-cell Therapy: Lessons to Be Learned from Noninvasive Profiling

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (3)
https://doi.org/10.1182/hem.V20.3.202334
Published: 2023
Articles

The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (2)
https://doi.org/10.1182/hem.V20.2.202324
Published: 2023
Articles

CAR T-cell Therapy: A Major Shift in the Treatment Landscape for Early-Relapse Aggressive B-Cell Lymphomas

Free
Chijioke Nze, MD, MPH, Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (1)
https://doi.org/10.1182/hem.V20.1.202318
Published: 2023
Articles

CELESTIMO: A Randomized Phase III Trial Examining the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide Versus Rituximab in Combination With Lenalidomide in Relapsed/Refractory Follicular Lymphoma

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2022) 19 (6)
https://doi.org/10.1182/hem.V19.6.2022610
Published: 2022
Articles

Shining a Light on a Randomized Trial: Ibrutinib Plus Rituximab and Bendamustine in Untreated Mantle Cell Lymphoma

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2022) 19 (5)
https://doi.org/10.1182/hem.V19.5.202258
Published: 2022
Articles

Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2022) 19 (4)
https://doi.org/10.1182/hem.V19.4.202247
Published: 2022
Articles

POLARIX: Is R-CHOP in the Rearview Mirror?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2022) 19 (3)
https://doi.org/10.1182/hem.V19.3.202235
Published: 2022
Articles

Navigating the Treatment Landscape of Advanced Follicular Lymphoma: Should You Consider a CAR, and Which Model?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2022) 19 (2)
https://doi.org/10.1182/hem.V19.2.202226
Published: 2022